Anticancer Res

1. MIYAKE R, Takeyama H, Manome Y, Koyama M, et al
   Thyroid Cancer With Autocrine Sialyl-fibronectin Depletion Has a Poor Prognosis due to EMT Progression.
   Anticancer Res. 2024;44:4561-4568.
   

   >> Share

   
   
2. NA YM, Park SC, An SY, Ma HU, et al
   Analysis of Initial Outcomes of Gas-insufflation One-step Single-port Transaxillary (GOSTA) Robotic Thyroidectomy for Thyroid Cancer.
   Anticancer Res. 2024;44:4585-4592.
   

   >> Share

   
   
3. KUGA R, Hashimoto K, Yamamoto H, Taniguchi M, et al
   Clinicopathological Review of Head and Neck Squamous Cell Carcinomas After Neoadjuvant Chemotherapy.
   Anticancer Res. 2024;44:4593-4603.
   

   >> Share

   
   
4. XU L, Tian A, Fan R, Lai J, et al
   Synchronous Pancreatic Ductal Adenocarcinoma and Nasopharyngeal Carcinoma With Associated Novel Pathogenic ATM Mutation.
   Anticancer Res. 2024;44:4605-4608.
   

   >> Share

   
   

   
   BMC Cancer

5. RZEPAKOWSKA A, Oledzka J, Daniel P, Mekarska M, et al
   Immunomodulatory role of tumor microenvironment on oncological outcomes in advanced laryngeal cancer.
   BMC Cancer. 2024;24:1219.
   

   >> Share

   
   
6. JIN J, Guo SS, Liu LT, Wen DX, et al
   Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
   BMC Cancer. 2024;24:1223.
   

   >> Share

   
   
7. YANG MH, Chen TH, Wang HM, Hsieh JC, et al
   Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen.
   BMC Cancer. 2024;24:1227.
   

   >> Share

   
   
8. WANG Y, Ma K, Zhang H, Wu L, et al
   Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis.
   BMC Cancer. 2024;24:1228.
   

   >> Share

   
   
9. THARIAT J, Pham TN, Coupey J, Clarisse B, et al
   CYRAD: a translational study assessing immune response to radiotherapy by photons or protons in postoperative head and neck cancer patients through circulating leukocyte subpopulations and cytokine levels.
   BMC Cancer. 2024;24:1230.
   

   >> Share

   
   

   
   BMC Surg

10. FUJIWARA Y, Endo S, Higashida M, Kubota H, et al
    The seven-day cumulative post-esophagectomy inflammatory response predicts cancer recurrence.
    BMC Surg. 2024;24:289.
    

    >> Share

    
    
11. WANG Q, Ge J, Wu H, Wu Q, et al
    Comparison of three-dimensional vs. two-dimensional assisted thoracoscopy for recurrent laryngeal nerve lymph nodes dissection in esophagectomy: a retrospective study.
    BMC Surg. 2024;24:278.
    

    >> Share

    
    

    
    Clin Cancer Res

12. CHAMSEDDINE I, Shah K, Lee H, Ehret F, et al
    Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis.
    Clin Cancer Res. 2024;30:4424-4433.
    

    >> Share

    
    

    
    Clin Nucl Med

13. EDAMADAKA Y, Parghane RV, Basu S
    Variable Tracer Avidity and Interlesional Heterogeneity on 18F-FDG, 68Ga-DOTATATE, and 68Ga-DOTA-FAPi-04 PET/CT Imaging in a Single Individual Patient With Progressive Metastatic Medullary Thyroid Carcinoma.
    Clin Nucl Med. 2024 Oct 4. doi: 10.1097/RLU.0000000000005469.
    

    >> Share

    
    

    
    Dis Esophagus

14. TANKEL J, Nevo Y, Al Shehhi R, Sakalla R, et al
    Impact of bulky loco-regional lymphadenopathy in esophageal adenocarcinoma on survival: a retrospective single center analysis.
    Dis Esophagus. 2024;37:doae046.
    

    >> Share

    
    
15. LOUGHNEY L, Murphy K, Tully R, Robb WB, et al
    The effect of a pre- and post-operative exercise program versus standard care on physical activity and sedentary behavior of patients with esophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (the PERIOP-OG Trial): a randomi
    Dis Esophagus. 2024;37:doae044.
    

    >> Share

    
    
16. WATANABE M, Takahashi N, Tamura M, Terayama M, et al
    Gastric conduit reconstruction after esophagectomy.
    Dis Esophagus. 2024;37:doae045.
    

    >> Share

    
    

    
    Head Neck

17. CUI Z, Kang H, Li H, Lee ED, et al
    CYLD Alterations Are Associated With Metastasis and Poor Prognosis in Human Papilloma Virus-Positive Head and Neck Cancer.
    Head Neck. 2024 Sep 30. doi: 10.1002/hed.27944.
    

    >> Share

    
    

    
    Int J Cancer

18. INOUE-CHOI M, Freedman ND, Etemadi A, Hashemian M, et al
    One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study.
    Int J Cancer. 2024;155:1944-1957.
    

    >> Share

    
    

    
    Int J Pediatr Otorhinolaryngol

19. THOMPSON HM, Hubbard MG, Ackah SA, Dewey A, et al
    Pediatric parathyroid carcinoma and hyperparathyroidism-jaw tumor syndrome: A case report and literature review.
    Int J Pediatr Otorhinolaryngol. 2024;186:112116.
    

    >> Share

    
    

    
    J Clin Oncol

20. CHEN WJ, Yu X, Lu YQ, Pfeiffer RM, et al
    Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial.
    J Clin Oncol. 2024 Oct 1:JCO2301296. doi: 10.1200/JCO.23.01296.
    

    >> Share

    
    
21. TOPKAN E, Somay E, Bascil S, Pehlivan B, et al
    Underrated But Significant Risk Factors of Osteoradionecrosis of the Jaw in Patients With Head and Neck Cancer.
    J Clin Oncol. 2024 Oct 3:JCO2401020. doi: 10.1200/JCO.24.01020.
    

    >> Share

    
    

    
    J Nucl Med

22. WRAY R, Mauguen A, Michaud L, Leithner D, et al
    Development of (18)F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance.
    J Nucl Med. 2024 Sep 12:jnumed.124.267775. doi: 10.2967/jnumed.124.267775.
    

    >> Share

    
    

    
    J Oral Maxillofac Surg

23. PATRICK MM, Amundson MS
    A Case of Profound Obstructive Sleep Apnea Secondary to an Unrecognized Lingual Angiomyxoma.
    J Oral Maxillofac Surg. 2024;82:1295-1303.
    

    >> Share

    
    
24. ETTINGER KS, Mohamed AK, Nathan JM, Vierkant RA, et al
    Patient-specific Implants Improve Volumetric Surgical Accuracy Compared to Stock Reconstruction Plates in Modern Paradigm Virtual Surgical Planning of Fibular Free Flaps for Head and Neck Reconstruction.
    J Oral Maxillofac Surg. 2024;82:1311-1328.
    

    >> Share

    
    

    
    Oral Oncol

25. TANG WZ, Xu WZ, Liu TH
    Exploring the potential of gemcitabine, capecitabine, and tislelizumab after anti-PD-1 treatment in nasopharyngeal carcinoma.
    Oral Oncol. 2024;159:107065.
    

    >> Share

    
    
26. YACOUB I, Qian JY, Nashed K, Youssef M, et al
    Radiation techniques and advancements in nasopharyngeal carcinoma.
    Oral Oncol. 2024;159:107060.
    

    >> Share

    
    
27. DAWSON A, Karimi AH, Shaikh MH, Gazala W, et al
    Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer.
    Oral Oncol. 2024;159:107061.
    

    >> Share

    
    
28. AKASHANAND, Zahiruddin QS, Jena D, Ballal S, et al
    Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990-2021.
    Oral Oncol. 2024;159:107063.
    

    >> Share

    
    
29. LECHIEN JR
    Surgical, Functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal Cancers: A systematic review.
    Oral Oncol. 2024;159:107047.
    

    >> Share

    
    
30. KEEFE K, McCrary HC, Wei M, Mark B, et al
    Risk of cardiovascular disease among head and neck cancer survivors: A population-based matched cohort study.
    Oral Oncol. 2024;159:107041.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

31. YOUSEF A, Nichol A, Luu B, Montesa C, et al
    Assessing Long-Term Quality of Life Concerns Through Survivorship Clinic in Head and Neck Cancer Patients.
    Otolaryngol Head Neck Surg. 2024 Oct 1. doi: 10.1002.
    

    >> Share

    
    
32. MASCARELLA MA, Richardson K, Mlynarek A, Hier MP, et al
    Neoadjuvant Capecitabine in Operable HPV-Negative Head and Neck Cancer: Fortuitous Findings in a Resource Constrained Setting.
    Otolaryngol Head Neck Surg. 2024 Sep 29. doi: 10.1002/ohn.1003.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share